Molecularly imprinted polymer of 5-methyluridine for solid-phase extraction of pyrimidine nucleoside cancer markers in urine.
Damien Jégourel, Raphaël Delépée, Florent Breton, Antoine Rolland, Richard Vidal, Luigi A Agrofoglio
Index: Bioorg. Med. Chem. 16(19) , 8932-9, (2008)
Full Text: HTML
Abstract
Normal and modified urinary nucleosides represent potential biomarkers for cancer diagnosis. To selectively extract modified nucleosides, we developed a molecularly imprinted polymer (MIP) of 5-methyluridine as selective material for molecularly imprinted solid-phase extraction (MISPE). The MIPs were obtained from vinyl-phenylboronate ester derivative of the template, acrylamide and pentaerythritol triacrylate co-polymer, and were tested in batch and cartridge experiments with aqueous samples. Our results indicated that the imprinted polymer was selective for pyrimidine nucleosides with a K(d) and a B(max) of 46 microM and 18 micromol/g, respectively. Finally, a MISPE of the most common pyrimidine nucleoside cancer markers in urine sample was realized.
Related Compounds
Related Articles:
2015-05-01
[Anal. Bioanal. Chem 407(13) , 3555-66, (2015)]
2015-01-01
[Sci. Rep. 5 , 13374, (2015)]
2015-07-17
[J. Chromatogr. A. 1403 , 54-62, (2015)]
2015-10-01
[PLoS Genet. 11 , e1005586, (2015)]
2005-01-01
[Nucleosides Nucleotides Nucleic Acids 24(5-7) , 815-8, (2005)]